Kaplan–Meier survival analysis revealed that the expression pattern of several ERAR lncRNA genes could classify ER+ breast cancer patients into high- or low-risk endocrine-resistant and distant metastasis groups. The gene discussed is ESR1; the disease is breast carcinoma.